Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

ClinicalTrials.gov ID: NCT00228384

Public ClinicalTrials.gov record NCT00228384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 4:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the performance of the GORE VIABAHN® Endoprosthesis compared to a bare nitinol stent for the treatment of superficial femoral artery (SFA) occlusive disease in long lesions.

Study identification

NCT ID
NCT00228384
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
W.L.Gore & Associates
Industry
Enrollment
148 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Jan 2011 (Actual)
Completion
Jan 2011 (Actual)
Last update posted
Jun 4, 2012

2005 – 2011

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Mayo Clinic Phoenix Phoenix Arizona 85054 —
Arkansas Heart Little Rock Arkansas 72211 —
Holy Cross Hospital Fort Lauderdale Florida 33308 —
Vascular Surgical Associate Austell Georgia 30106 —
Midwest Heart Foundation Lombard Illinois 60148 —
Midwest Institute for Minimally Invasive Therapy Melrose Park Illinois 60160 —
St Francis Medical Center Peoria Illinois 61637 —
St. Johns Hospital/Prairie Education Research Springfield Illinois 62701 —
Ochsner Clinic New Orleans Louisiana 70121 —
Washington University St Louis Missouri 63110 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Midwest Cardiology Research Foundation Columbus Ohio 43214 —
Heritage Valley Health Systems Beaver Pennsylvania 15009 —
Allegheney General Hospital Pittsburgh Pennsylvania 15212 —
St Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00228384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2012 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00228384 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →